Published in Hum Mutat on February 01, 2003
MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J (2003) 3.77
Somatic LKB1 mutations promote cervical cancer progression. PLoS One (2009) 2.21
Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. PLoS One (2009) 2.03
Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J Biol Chem (2008) 1.31
LKB1, the multitasking tumour suppressor kinase. J Clin Pathol (2005) 1.07
LKB1 catalytic activity contributes to estrogen receptor alpha signaling. Mol Biol Cell (2009) 1.00
Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome. Dig Dis Sci (2007) 0.96
Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Mol Genet Genomics (2005) 0.93
A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene (2006) 0.85
Akt blocks the tumor suppressor activity of LKB1 by promoting phosphorylation-dependent nuclear retention through 14-3-3 proteins. Am J Transl Res (2012) 0.79
Single nucleotide variations in cultured cancer cells: Effect of mismatch repair. Mutat Res (2017) 0.75
Resveratrol-Induced AMP-Activated Protein Kinase Activation Is Cell-Type Dependent: Lessons from Basic Research for Clinical Application. Nutrients (2017) 0.75
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1996) 26.30
Role of translocation in the activation and function of protein kinase B. J Biol Chem (1997) 7.29
The PI3K-PDK1 connection: more than just a road to PKB. Biochem J (2000) 7.00
PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci (2001) 6.11
Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J (1998) 5.70
Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science (1998) 5.62
Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J (1999) 4.80
Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J (2001) 4.40
The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol (2000) 4.24
Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J (2003) 3.62
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J (2001) 3.58
Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J (2000) 3.53
Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem J (1996) 3.13
PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol (1999) 3.05
Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem J (1999) 3.03
Neuroendocrine differentiation in Ewing's sarcomas and primitive neuroectodermal tumors revealed by reverse transcriptase-polymerase chain reaction of chromogranin mRNA. Diagn Mol Pathol (1998) 2.86
Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J (1999) 2.74
Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem J (1998) 2.73
Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta. J Biol Chem (1997) 2.70
Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. EMBO J (2000) 2.67
Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J (1996) 2.59
Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast. Curr Biol (1999) 2.56
Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem (1997) 2.43
Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol (1999) 2.38
Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell (2001) 2.11
Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett (1997) 2.01
The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J (1998) 1.95
A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Czeta (PKCzeta ) and PKC-related kinase 2 by PDK1. J Biol Chem (2000) 1.88
PDK1, one of the missing links in insulin signal transduction? FEBS Lett (1997) 1.80
Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett (2000) 1.73
Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg (2007) 1.73
DAPP1: a dual adaptor for phosphotyrosine and 3-phosphoinositides. Biochem J (1999) 1.69
Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252. J Biol Chem (1999) 1.61
Characterisation of a plant 3-phosphoinositide-dependent protein kinase-1 homologue which contains a pleckstrin homology domain. FEBS Lett (1999) 1.53
A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ (2006) 1.48
Preferences of patients, their family caregivers and vascular surgeons in the choice of abdominal aortic aneurysms treatment options: the PREFER study. Eur J Vasc Endovasc Surg (2011) 1.47
Prognostic value of captopril renal scintigraphy in renovascular hypertension. J Nucl Med (1992) 1.45
STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res (1998) 1.45
Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum Mol Genet (2000) 1.43
Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology (1998) 1.42
[Infection surveillance in intensive care units. Preliminary results of a multicenter GiViTI study in 71 Italian ICUs]. Minerva Anestesiol (2004) 1.40
Phenformin as prophylaxis and therapy in breast cancer xenografts. Br J Cancer (2012) 1.33
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg (2005) 1.30
Crystal structure of the phosphatidylinositol 3,4-bisphosphate-binding pleckstrin homology (PH) domain of tandem PH-domain-containing protein 1 (TAPP1): molecular basis of lipid specificity. Biochem J (2001) 1.27
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol Cell Biol (2001) 1.26
Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP) Am J Hum Genet (1993) 1.25
Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol (2000) 1.24
Cancer risks in LKB1 germline mutation carriers. Gut (2006) 1.24
Use of kinase inhibitors to dissect signaling pathways. Methods Mol Biol (2000) 1.22
Network analyses of Y-chromosomal types in Europe, northern Africa, and western Asia reveal specific patterns of geographic distribution. Am J Hum Genet (1998) 1.21
Molecular cloning of cDNA encoding the 110 kDa and 21 kDa regulatory subunits of smooth muscle protein phosphatase 1M. FEBS Lett (1994) 1.20
Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol (2008) 1.20
Phosphoinositide-regulated kinases and phosphoinositide phosphatases. Chem Rev (2001) 1.18
Identification of carotid 'vulnerable plaque' by contrast-enhanced ultrasonography: correlation with plaque histology, symptoms and cerebral computed tomography. Eur J Vasc Endovasc Surg (2010) 1.16
Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement Of the mitogen- and stress-activated protein kinase 1. J Biol Chem (2000) 1.16
Two novel mutations and a new STK11/LKB1 gene isoform in Peutz-Jeghers patients. Hum Mutat (2002) 1.16
Phosphoinositide 3-kinase-dependent phosphorylation of the dual adaptor for phosphotyrosine and 3-phosphoinositides by the Src family of tyrosine kinase. Biochem J (2000) 1.08
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol (1993) 1.07
Nerve growth factor promotes activation of the alpha, beta and gamma isoforms of protein kinase B in PC12 pheochromocytoma cells. Eur J Biochem (1998) 1.02
Aneurysmal change at or above the proximal anastomosis after infrarenal aortic grafting. J Vasc Surg (1992) 1.02
A silent mutation in exon 14 of the APC gene is associated with exon skipping in a FAP family. J Med Genet (2001) 1.02
An unusual dicentric Y chromosome with a functional centromere with no detectable alpha-satellite. Hum Genet (1996) 1.01
Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Clin Genet (2007) 1.00
Sister chromatid exchange (SCE) and micronucleus (MN) frequencies in lymphocytes of gasoline station attendants. Mutat Res (1998) 0.99
Mesenchymal stem cell interaction with a non-woven hyaluronan-based scaffold suitable for tissue repair. J Anat (2008) 0.98
Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects. Curr Pharm Des (2006) 0.98
Partial purification and characterization of a wortmannin-sensitive and insulin-stimulated protein kinase that activates heart 6-phosphofructo-2-kinase. Biochem J (2000) 0.98
Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B. J Biol Chem (1999) 0.97
COACH syndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation. Am J Med Genet (1996) 0.96
The aetiology of the cat eye syndrome reconsidered. J Med Genet (1981) 0.95
Mechanisms of renal release of renin by electrical stimulation of the brainstem in the cat. Circ Res (1974) 0.95
Evaluation of hypertensive patients by means of captopril enhanced renal scintigraphy with technetium-99m DTPA. J Nucl Med (1989) 0.95
Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. Int J Cancer (1998) 0.94
Novel splice isoforms of STRADalpha differentially affect LKB1 activity, complex assembly and subcellular localization. Cancer Biol Ther (2007) 0.93
A Monte Carlo approach for estimation of haplotype probabilities in half-sib families. J Dairy Sci (2004) 0.93
Peroxovanadate induces tyrosine phosphorylation of phosphoinositide-dependent protein kinase-1 potential involvement of src kinase. Eur J Biochem (2000) 0.92
Familial adenomatous polyposis: identification of a new frameshift mutation of the APC gene in an Italian family. Biochem Biophys Res Commun (1992) 0.92
New phenotypic aspects in a family with Lynch syndrome II. Cancer (1987) 0.92
A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families. Cancer Res (2001) 0.92
Nonpenetrating deep sclerectomy with reticulated hyaluronic acid implant versus punch trabeculectomy: a prospective clinical trial. Eur J Ophthalmol (2008) 0.92
Life expectancy in patients with hereditary haemorrhagic telangiectasia. QJM (2006) 0.91
Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results. Radiol Med (2007) 0.91
Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance. J Pathol (2000) 0.91
Differentially expressed genes associated with Staphylococcus aureus mastitis in dairy goats. Vet Immunol Immunopathol (2009) 0.90
An immunohistochemical study of inflammatory abdominal aortic aneurysms. J Submicrosc Cytol Pathol (1993) 0.90